VNDD
  • Home
  • Search
  • Methodology
  • Contact
<Return to Disease List
Gangliosidosis Type II (GM2/Sandhoff-Like Disease)
  • Description
  • Signalment
  • Clinical Features
  • Neurolocalization
  • Genetics
<
>
 Gangliosidosis Type II (GM2) is a deficiency in the enzyme beta-galactosidase which causes defects in the catabolism of gangliosides resulting in their accumulation in neuronal lysosomes.
Age of Onset:  Less than 18 months of age
Sex Predisposition: Any sex of animal can be affected
Clinical Course:
​Clinical signs worsen over time
Clinical Signs:
Behavioral/Mental Awareness 
Drowsiness
Anxiety
Decreased responsiveness to verbal commands
Restless
Abrupt change in consciousness when laying down


Posture and Appearance 
Wide-based stance in all limbs
Altered tail carriage – tail down

Movement 
Stiff gait 
Falling
Ataxia
Tetraparesis
Intention tremor
Inability to climb up or down stairs
Involuntary twitching/jerking motions
Circling
Hypermetria
Myoclonus


Cranial Nerves 
Decreased bilateral corneal reflex
Decreased/Absent bilateral menace response
Impaired vision
Myoclonic twitching of the face and lips elicited by cranial nerve testing


Spinal Reflexes
Excessively brisk in all four limbs
Reflex testing of the front limbs resulting in myoclonic jerking of the rear limbs and vice-versa
 
Special Functions (e.g. respiration; urination) 
Vomiting
Inappetence

Muscle Atrophy
Atrophic appearance of shoulder girdle and distal limbs

Brain and spinal cord
Autosomal recessive inheritance of mutated HEXB gene
To read more about this disease click below:
References
Picture
Contact us:
[email protected]

Privacy Policy
Terms and Conditions​
Cookie Policy
Disclaimer
  • Home
  • Search
  • Methodology
  • Contact